Correction: A Phase II Trial of 1st-Line Modified-Folfoxiri Plus Bevacizumab Treatment for Metastatic Colorectal Cancer Harboring RAS Mutation: JACCRO CC-11
Oncotarget - United States
doi 10.18632/oncotarget.25775
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 6, 2018
Authors
Publisher
Impact Journals, LLC